Global Anatomic Pathology Track and Trace Solutions Market 2024-2028

The anatomic pathology track and trace solutions market is forecasted to grow by USD 549.67 mn during 2023-2028, accelerating at a CAGR of 14.47% during the forecast period. The report on the anatomic pathology track and trace solutions market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of automated systems in laboratories, rising demand for timely disease diagnosis, and high frequency of human errors in anatomic pathology tracking and tracing.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	12.84%
CAGR	14.47%
Incremental Value	$549.67mn

Technavio's anatomic pathology track and trace solutions market is segmented as below:

By End-user

Hospital laboratories
Independent and reference laboratories
CRO and others

By Technology

Barcode
RFID

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the digitization of healthcare as one of the prime reasons driving the anatomic pathology track and trace solutions market growth during the next few years. Also, integration of artificial intelligence into anatomic pathology track-and-trace solutions and increasing investments in healthcare industry will lead to sizable demand in the market.

The report on the anatomic pathology track and trace solutions market covers the following areas:

Anatomic pathology track and trace solutions market sizing
Anatomic pathology track and trace solutions market forecast
Anatomic pathology track and trace solutions market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading anatomic pathology track and trace solutions market vendors that include Agilent Technologies Inc., cerebrum corp, Clinisys Inc., CompuGroup Medical SE and Co. KGaA, Danaher Corp., F. Hoffmann La Roche Ltd., Mikroscan Technologies Inc., MILESTONE MEDICAL, PHC Holdings Corp., Psyche Systems Corp, Sakura Finetek USA Inc., Siemens Healthineers AG, Visiopharm AS, Cirdan, Indica Labs Inc., LigoLab Information Systems, Pathcore Inc, Proscia Inc., XIFIN Inc., and Voicebrook Inc.. Also, the anatomic pathology track and trace solutions market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR40179

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global anatomic pathology track and trace solutions market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global anatomic pathology track and trace solutions market 2018 - 2022 ($ million)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Technology Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technology Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospital laboratories - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospital laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Hospital laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Hospital laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospital laboratories - Year-over-year growth 2023-2028 (%)
6.4 Independent and reference laboratories - Market size and forecast 2023-2028
Exhibit 38: Chart on Independent and reference laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Independent and reference laboratories - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Independent and reference laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Independent and reference laboratories - Year-over-year growth 2023-2028 (%)
6.5 CRO and others - Market size and forecast 2023-2028
Exhibit 42: Chart on CRO and others - Market size and forecast 2023-2028 ($ million)
Exhibit 43: Data Table on CRO and others - Market size and forecast 2023-2028 ($ million)
Exhibit 44: Chart on CRO and others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on CRO and others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ million)
Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Technology

7.1 Market segments
Exhibit 48: Chart on Technology - Market share 2023-2028 (%)
Exhibit 49: Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Exhibit 50: Chart on Comparison by Technology
Exhibit 51: Data Table on Comparison by Technology
7.3 Barcode - Market size and forecast 2023-2028
Exhibit 52: Chart on Barcode - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Barcode - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Barcode - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Barcode - Year-over-year growth 2023-2028 (%)
7.4 RFID - Market size and forecast 2023-2028
Exhibit 56: Chart on RFID - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on RFID - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on RFID - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on RFID - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Technology
Exhibit 60: Market opportunity by Technology ($ million)
Exhibit 61: Data Table on Market opportunity by Technology ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Agilent Technologies Inc.
Exhibit 111: Agilent Technologies Inc. - Overview
Exhibit 112: Agilent Technologies Inc. - Business segments
Exhibit 113: Agilent Technologies Inc. - Key offerings
Exhibit 114: Agilent Technologies Inc. - Segment focus
12.4 cerebrum corp
Exhibit 115: cerebrum corp - Overview
Exhibit 116: cerebrum corp - Product / Service
Exhibit 117: cerebrum corp - Key offerings
12.5 Clinisys Inc.
Exhibit 118: Clinisys Inc. - Overview
Exhibit 119: Clinisys Inc. - Product / Service
Exhibit 120: Clinisys Inc. - Key offerings
12.6 CompuGroup Medical SE and Co. KGaA
Exhibit 121: CompuGroup Medical SE and Co. KGaA - Overview
Exhibit 122: CompuGroup Medical SE and Co. KGaA - Business segments
Exhibit 123: CompuGroup Medical SE and Co. KGaA - Key offerings
Exhibit 124: CompuGroup Medical SE and Co. KGaA - Segment focus
12.7 Danaher Corp.
Exhibit 125: Danaher Corp. - Overview
Exhibit 126: Danaher Corp. - Business segments
Exhibit 127: Danaher Corp. - Key news
Exhibit 128: Danaher Corp. - Key offerings
Exhibit 129: Danaher Corp. - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 130: F. Hoffmann La Roche Ltd. - Overview
Exhibit 131: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 132: F. Hoffmann La Roche Ltd. - Key news
Exhibit 133: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 134: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Mikroscan Technologies Inc.
Exhibit 135: Mikroscan Technologies Inc. - Overview
Exhibit 136: Mikroscan Technologies Inc. - Product / Service
Exhibit 137: Mikroscan Technologies Inc. - Key offerings
12.10 MILESTONE MEDICAL
Exhibit 138: MILESTONE MEDICAL - Overview
Exhibit 139: MILESTONE MEDICAL - Product / Service
Exhibit 140: MILESTONE MEDICAL - Key offerings
12.11 PHC Holdings Corp.
Exhibit 141: PHC Holdings Corp. - Overview
Exhibit 142: PHC Holdings Corp. - Business segments
Exhibit 143: PHC Holdings Corp. - Key offerings
Exhibit 144: PHC Holdings Corp. - Segment focus
12.12 Psyche Systems Corp
Exhibit 145: Psyche Systems Corp - Overview
Exhibit 146: Psyche Systems Corp - Product / Service
Exhibit 147: Psyche Systems Corp - Key offerings
12.13 Sakura Finetek USA Inc.
Exhibit 148: Sakura Finetek USA Inc. - Overview
Exhibit 149: Sakura Finetek USA Inc. - Product / Service
Exhibit 150: Sakura Finetek USA Inc. - Key offerings
12.14 Siemens Healthineers AG
Exhibit 151: Siemens Healthineers AG - Overview
Exhibit 152: Siemens Healthineers AG - Business segments
Exhibit 153: Siemens Healthineers AG - Key news
Exhibit 154: Siemens Healthineers AG - Key offerings
Exhibit 155: Siemens Healthineers AG - Segment focus
12.15 Visiopharm AS
Exhibit 156: Visiopharm AS - Overview
Exhibit 157: Visiopharm AS - Product / Service
Exhibit 158: Visiopharm AS - Key offerings
12.16 Voicebrook Inc.
Exhibit 159: Voicebrook Inc. - Overview
Exhibit 160: Voicebrook Inc. - Product / Service
Exhibit 161: Voicebrook Inc. - Key offerings
12.17 XIFIN Inc.
Exhibit 162: XIFIN Inc. - Overview
Exhibit 163: XIFIN Inc. - Product / Service
Exhibit 164: XIFIN Inc. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations